Lower urinary tract dysfunction and Parkinsonian syndromes;Troubles vésico-sphintériens des syndromes parkinsoniens

Progres en Urologie

Volumn 17, Issue 3, 2007, Pages 393-398

  Vassel, Ph ^a   Robain, G ^a   Pichon, J ^a   Chartier Kastler, E ^a   Ruffion, A ^a  

^a NONE

Author keywords

Multisystem atrophy; Neurogenic bladder; Parkinson's disease; Parkinsonian syndromes

Indexed keywords

EID: 34250866822     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1166-7087(07)92336-2     Document Type: Article

References (34)

1. La Maladie de Parkinson : critères diagnostiques et thérapeutiques. In, Conférence de consensus Paris: ANAES; 2000
2. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 2000;68:429-33
3. Singer C. Urinary dysfunction in Parkinson's disease. Clin Neurosci 1998;5:78-86
4. Siroky MB. Neurological disorders cerebrovascular disease and parkinsonism. Urol Clin North Am 2003;30:27-47, v
5. Stocchi F, Carbone A, Inghilleri M, et al. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 1997;62:507-11
6. Murnaghan GF. Neurogenic disorders of the bladder in Parkinsonism. Br J Urol 1961;33:403-9
7. Berger Y, Salinas JN, Blaivas JG. Urodynamic differentiation of parkinson disease and the shy drager syndrome. In; 1990:117-21
8. Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999;67:620-3
9. Bonnet AM, Pichon J, Vidailhet M, et al. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov Disord 1997;12:509-13
10. Sakakibara R, Hattori T, Uchiyama T, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 2000;68:65-9
11. Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 1997;80:100-4
12. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001;71:600-6
13. Martinelli P, Coccagna G, Rizzuto N, Lugaresi E. Changes in systemic arterial pressure during sleep in Shy-Drager syndrome. Sleep 1981;4:139-46
14. Kirby R, Fowler C, Gosling J, Bannister R. Urethro-vesical dysfunction in progressive autonomic failure with multiple system atrophy. J Neurol Neurosurg Psychiatry 1986;49:554-62
15. Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994;151:1336-41
16. Fowler CJ. Urinary disorders in Parkinson's disease and multiple system atrophy. Fund Neurol 2001;16:277-82
17. Pramstaller PP, Wenning GK, Smith SJ, et al. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:618-21
18. Tison F, Arne P, Sourgen C, Chrysostome V, Yeklef F. The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 2000;15:1148-57
19. Valldeoriola F, Valls-Sole J, Tolosa ES, Marti MJ. Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 1995;10:550-5
20. Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 2001;16:600-7
21. Andersen JT, Bradley WE. Cystometric, sphincter and electromyelographic abnormalities in Parkinson's disease. J Urol 1976;116:75-8
22. Edwards KR, O'Connor JT. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc 2002;50:1165-6
23. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995;10:337-40
24. Sakakibara R, Hattori T, Uchiyama T, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 2000;79:191-5
25. Uchiyama T, Sakakibara R, Hattori T, Yamanishi T. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Mov Disord 2003;18:573-8
26. Winge K, Werdelin LM, Nielsen KK, Stimpel H. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodyn. 2004;23(7):689-96.
27. Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol 1988;140:117-8
28. Pepper PV, Goldstein MK. Postoperative complications in Parkinson's disease. J Am Geriatr Soc 1999;47:967-72
29. Seif C, Herzog J, van der Horst C et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004;55:118-20
30. Finazzi-Agro E, Peppe A, D'Amico A, et al. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J Urol 2003;169:1388-91
31. Hattori T, Yasuda K, Kita K, Hirayama K. Voiding dysfunction in Parkinson's disease. Jpn J Psychiatry Neurol 1992;46:181-6
32. Pavlakis AJ, Siroky MB, Goldstein I, Krane RJ. Neurourologic findings in Parkinson's disease. J Urol 1983;129:80-3
33. Berger Y, Blaivas JG, DeLaRocha ER, Salinas JM. Urodynamic findings in Parkinson's disease. J Urol 1987;138:836-8
34. Araki I, Kitahara M, Oida T, Kuno S. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J Urol 2000;164:1640-3